We're just so happy
The Sunday Mirror|July 07, 2024
CF twin mum's relief over NHS deal
MATTHEW BARBOUR
We're just so happy

REVOLUTIONARY drugs that can double the life expectancy of people with cystic fibrosis will be available more widely on the NHS, thanks to a deal with the maker.

Cystic fibrosis is a life-limiting lung condition, with sufferers previously expected to live only until their late 30s without a rare lung transplant.

But one CFTR modulator medicine, Kaftrio, has been shown to relieve symptoms and extend life expectancy by up to 40 years in 90% of patients.

This story is from the July 07, 2024 edition of The Sunday Mirror.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the July 07, 2024 edition of The Sunday Mirror.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM THE SUNDAY MIRRORView All